Filing Details

Accession Number:
0001179110-12-006972
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-19 19:10:56
Reporting Period:
2012-04-17
Filing Date:
2012-04-19
Accepted Time:
2012-04-19 18:10:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820237 Gen Probe Inc GPRO Surgical & Medical Instruments & Apparatus (3841) 330044608
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1205465 Carl Hull Gen-Probe Incorporated
10210 Genetic Center Drive
San Diego CA 92121
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-04-17 7,083 $47.42 54,050 No 4 M Direct
Common Stock Disposition 2012-04-17 5,883 $66.23 48,167 No 4 S Direct
Common Stock Disposition 2012-04-17 1,200 $66.65 46,967 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2012-04-17 7,083 $0.00 7,083 $47.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
62,188 2014-03-01 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2011.
  2. This transaction was executed in multiple trades at prices ranging from $65.61 to $66.60. The price reported above reflects the weighted average sale price for these transactions. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the reported transactions were effected.
  3. This transaction was executed in multiple trades at prices ranging from $66.61 to $66.675. The price reported above reflects the weighted average sale price for these transactions. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the reported transactions were effected.
  4. The shares subject to the stock option vested and became fully exercisable as of March 1, 2011.